Germline duplication of ATG2B and GSKIP predisposes to familial myeloid malignancies
CHARRIER, S.
Approches génétiques intégrées et nouvelles thérapies pour les maladies rares [INTEGRARE]
< Réduire
Approches génétiques intégrées et nouvelles thérapies pour les maladies rares [INTEGRARE]
Langue
en
Article de revue
Ce document a été publié dans
Nat Genet. 2015-10, vol. 47, n° 10, p. 1131-40
Résumé en anglais
No major predisposition gene for familial myeloproliferative neoplasms (MPN) has been identified. Here we demonstrate that the autosomal dominant transmission of a 700-kb duplication in four genetically related families ...Lire la suite >
No major predisposition gene for familial myeloproliferative neoplasms (MPN) has been identified. Here we demonstrate that the autosomal dominant transmission of a 700-kb duplication in four genetically related families predisposes to myeloid malignancies, including MPN, frequently progressing to leukemia. Using induced pluripotent stem cells and primary cells, we demonstrate that overexpression of ATG2B and GSKIP enhances hematopoietic progenitor differentiation, including of megakaryocytes, by increasing progenitor sensitivity to thrombopoietin (TPO). ATG2B and GSKIP cooperate with acquired JAK2, MPL and CALR mutations during MPN development. Thus, the germline duplication may change the fitness of cells harboring signaling pathway mutations and increases the probability of disease development.< Réduire
Origine
Importé de halUnités de recherche